Columbus Spinal Stimulator Lawsuits: 25% Failures

In 2023 alone, over 100,000 Americans received a spinal cord stimulator implant for chronic pain management, a figure that continues to rise as device technology advances. However, this growth has coincided with a concerning increase in reports of device malfunctions and patient injuries, leading to a surge in a particular spinal cord stimulator lawsuit. For individuals in Columbus who have experienced adverse effects, understanding the intricacies of these claims is paramount. How do these complex medical device lawsuits truly impact the lives of affected Georgians?

25% of Spinal Cord Stimulator Implants Require Revision Within Three Years

A staggering statistic from a 2022 study published in The Clinical Journal of Pain indicates that approximately 25% of spinal cord stimulator (SCS) implants necessitate revision surgery within three years of the initial procedure. This figure is not merely an academic point. It represents thousands of individuals in Georgia, and specifically in Columbus, facing additional surgeries, prolonged recovery periods, and heightened risks. When a patient undergoes SCS implantation, the expectation is long-term pain relief, not a return to the operating table months or a few years later. These revisions are often due to lead migration, hardware malfunction, or inadequate pain relief, all factors that can form the basis of a product liability claim. For a Columbus resident, another surgery means more time away from work, additional co-pays, and the emotional toll of repeated medical interventions. I’ve seen firsthand how these unexpected complications disrupt lives, transforming a hopeful solution into a new source of suffering.

Over 1,500 Adverse Event Reports Annually Linked to SCS Devices

The U.S. Food and Drug Administration (FDA) receives over 1,500 adverse event reports annually concerning spinal cord stimulator devices. These reports, accessible through the MAUDE database, detail a wide array of problems, from severe infections and neurological damage to device fractures and battery failures. While not every report leads to a lawsuit, the sheer volume shows a systemic issue with the reliability and safety of these implants. Consider the impact on a patient in Columbus who experiences a sudden cessation of therapy due to battery failure, or worse, develops a serious infection requiring hospitalization at St. Francis-Emory Healthcare. Such events are not minor inconveniences. They are debilitating and can lead to permanent injury. When we analyze these reports, we look for patterns, common failure modes, and whether manufacturers issued timely warnings or recalls. The consistency of certain complaints across numerous devices from various manufacturers is particularly concerning and often points to underlying design or manufacturing flaws that should have been addressed.

$2.5 Million Average Verdict in SCS Product Liability Cases

While each case is unique and depends heavily on the specific injuries and jurisdiction, an analysis of publicly available data on successful spinal cord stimulator product liability cases reveals an average verdict or settlement value around $2.5 million. This figure reflects compensation for extensive medical bills, lost income, future earning capacity, and significant pain and suffering claims. It is important to understand that this is an average. Some cases settle for less, while others, particularly those involving catastrophic injury or wrongful death, can far exceed this amount. For someone in Columbus who has suffered permanent neurological damage or has been rendered unable to work due to a faulty SCS device, a substantial award is not a windfall. It is a necessary measure to cover lifelong care, adapt their living situation, and compensate for the deep loss of quality of life. My experience in Georgia courts, including the Muscogee County Superior Court, shows that juries are often sympathetic to individuals who trusted a medical device to alleviate pain only to find it caused more harm. They understand the financial and emotional devastation these injuries inflict.

Georgia’s Statute of Limitations: Two Years from Injury Discovery

In Georgia, the statute of limitations for personal injury claims, including those stemming from defective medical devices, is generally two years from the date the injury was discovered or reasonably should have been discovered. This is codified in O.C.G.A. Section 9-3-33. This two-year window is a critical, non-negotiable deadline. Many individuals, especially those dealing with chronic pain and ongoing medical treatments, may not immediately realize their complications are due to a device defect rather than a natural progression of their condition. This is where the “discovery rule” becomes vital. If a patient in Columbus undergoes SCS implantation in 2023, but only receives a diagnosis in late 2024 that their persistent pain or new symptoms are directly attributable to a device malfunction, their two-year clock may start from that later discovery date. However, proving the exact date of discovery can be complex and requires careful documentation and legal strategy. My firm always advises potential clients to seek legal counsel as soon as they suspect a device-related injury, ensuring all deadlines are met and evidence is preserved. Waiting too long can extinguish an otherwise valid claim, regardless of the severity of the injury.

Conventional Wisdom: “All Medical Devices Carry Risks”

The conventional wisdom often touted by medical device manufacturers and, at times, by some medical professionals, is that “all medical devices carry inherent risks, and patients sign consent forms acknowledging them.” While it is true that every medical procedure and device has potential risks, this blanket statement often serves to deflect responsibility from genuine product defects. I strongly disagree with the notion that a patient’s signed consent form absolves a manufacturer of its duty to produce a safe, well-designed, and properly tested product. Consent forms typically outline known, foreseeable risks. They do not, and cannot, absolve a company from liability for manufacturing defects, design flaws that render a device unreasonably dangerous, or a failure to warn about risks that were known or should have been known at the time of sale. If a spinal cord stimulator fractures due to a material weakness that could have been prevented with better quality control, that is not an “inherent risk” a patient should simply accept. That is a product defect. My position is that patients consent to known risks, not to manufacturing negligence or design errors. The legal system in Georgia, through product liability law, holds manufacturers accountable for these failures, ensuring that patients who suffer harm due to preventable defects have recourse. It is a fundamental principle of consumer safety that manufacturers must stand behind their products, especially those implanted in the human body.

For individuals in Columbus working through the aftermath of a spinal cord stimulator injury, securing legal guidance is not merely advisable, it is a critical step toward understanding your rights and pursuing justice.